Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2018-07-17 2018-05-22
Drug Identification Number 02260077 02260077
Brand name APO-BRIMONIDINE APO-BRIMONIDINE
Common or Proper name BRIMONIDINE BRIMONIDINE
Company Name APOTEX INC APOTEX INC
Ingredients BRIMONIDINE TARTRATE BRIMONIDINE TARTRATE
Strength(s) 0.2% 0.2%
Dosage form(s) SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5 ML & 10 ML 5 ML & 10 ML
ATC code S01EA S01EA
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-05-21 2018-05-21
Estimated end date 2018-07-16 2018-07-16
Actual end date 2018-07-16
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments